echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Peptide News > Daily development of new drugs for Parkinson's disease can inhibit abnormal accumulation of protein

    Daily development of new drugs for Parkinson's disease can inhibit abnormal accumulation of protein

    • Last Update: 2019-07-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, Osaka University and other institutions in Japan announced that they have developed new drugs that can inhibit the accumulation of proteins related to Parkinson's disease, which have been confirmed to have the effect of improving the symptoms of Parkinson's disease in animal experiments   Parkinson's disease is thought to be related to the abnormal accumulation of a protein called "α - synuclein" in the brain, so far there is no fundamental treatment Research teams from Osaka University and Tokyo Medical and Dental University have recently developed oligonucleotide drugs that inhibit the accumulation of "α - synuclein", which can bind to and block the synthesis of "α - synuclein" gene, thus inhibiting the accumulation of this protein The researchers found that the accumulation of "α - synuclein" in the Parkinson's disease model mice treated with the drug was inhibited, and the movement disorder was also improved   The team said it looked forward to the research results and methods can become a landmark treatment for Parkinson's disease, and also look forward to its application in the treatment of other neurological diseases Relevant research results have been published in the British Journal scientific report.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.